TGFB1 and preeclampsia: In our study, we focused on the impact of the p38 MAPK activation by TGF-β1 for 48 h of treatment, corresponding to a more “chronic-like” scheme that may occurs during early onset preeclampsia as circulating TGF-β1 levels are increased [14,36].